We are live on
!
Find out more
Calamos Advisors Portfolio holdings
AUM
$28.2B
1-Year Est. Return
21.78%
This Fund
S&P 500
This Quarter
Est. Return
+2.38%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$16.4B
AUM Growth
+$994M
(+6.5%)
Cap. Flow
-$2.67B
Cap. Flow
% of AUM
-16.31%
Top 10 Holdings %
Top 10 Hldgs %
19.9%
Holding
653
New
51
Increased
212
Reduced
120
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$65.8M |
| 2 |
Cboe Global Markets
CBOE
|
+$65.4M |
| 3 |
Elevance Health
ELV
|
+$49.3M |
| 4 |
Mohawk Industries
MHK
|
+$49.2M |
| 5 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$44.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ANTX
Anthem, Inc.
ANTX
|
+$77.5M |
| 2 |
AGN
Allergan plc
AGN
|
+$69.6M |
| 3 |
AbbVie
ABBV
|
+$35.3M |
| 4 |
FRC
First Republic Bank
FRC
|
+$31.7M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$30.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 11.47% |
| 2 | Technology | 8.96% |
| 3 | Healthcare | 8.59% |
| 4 | Communication Services | 6.53% |
| 5 | Consumer Discretionary | 6.37% |
Similar funds
PCH
N
TWC
FDCDDQ
NA
Calamos Advisors's Q2 2018 Portfolio in Review
As of Q2 2018, Calamos Advisors held 653 positions worth $16.4B, up 6.5% from $15.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Calamos Advisors withdrew a net $2.67B in Q2 2018, closing 58 positions and reducing 120 holdings. Its most notable exit was Anthem, Inc., an estimated $77.5M position sold in full.
By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 11% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Calamos Advisors opened a new position in Cboe Global Markets worth $64.5M.
- Calamos Advisors's largest Q2 2018 buy was Cboe Global Markets: 619,398 shares worth $64.5M.
- Calamos Advisors added most to Goldman Sachs in Q2 2018, an estimated $65.8M increase.
- Calamos Advisors's biggest Q2 2018 reduction was Allergan plc, cutting an estimated $69.6M.
- Calamos Advisors fully exited Anthem, Inc. in Q2 2018, selling an estimated $77.5M.
- Calamos Advisors's ten largest holdings make up 20% of its $16.4B portfolio in Q2 2018.
- Calamos Advisors opened 51 new positions and closed 58 in Q2 2018.
- Calamos Advisors's portfolio value rose 6.5% quarter-over-quarter to $16.4B.
Based on Calamos Advisors's 13F filing for Q2 2018, filed 17 Jul 2018.